Fingerprint
Dive into the research topics of 'Doxorubicin and Olaratumab Versus Doxorubicin, Ifosfamide, and Mesna for Treatment of Advanced Soft Tissue Sarcomas'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Doxorubicin and Olaratumab Versus Doxorubicin, Ifosfamide, and Mesna for Treatment of Advanced Soft Tissue Sarcomas
Kathryn J. Hammer, Vanessa C. Copeland, Elizabeth T. Loggers, Seth M. Pollack, Michael J. Wagner, Lee D. Cranmer
Research output: Contribution to journal › Article › peer-review
6
Scopus
citations